ï»¿<body>
	<style type="text/css">
		.cs1AB6177D{text-align:left;text-indent:0pt;margin:0pt 0pt 8pt 0pt;line-height:2}
		.csE736517A{color:#000000;background-color:transparent;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;}
		.cs9FD43C8C{text-align:left;text-indent:36pt;margin:0pt 0pt 8pt 0pt;line-height:2}
		.csF2E808A1{color:#000000;background-color:transparent;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-decoration: underline;}
		.csDB801AB8{text-align:left;text-indent:36pt;margin:0pt 0pt 8pt 0pt;line-height:1.1583333}
	</style>
	<p class="cs1AB6177D"><span class="csE736517A">SB939 HFA Pushkin 4-9 #1</span></p><p class="cs1AB6177D"><span class="csE736517A">	Delegate Pushkin moves to amend the bill on page 1, section 4a after line 10, by inserting a new subsection (f), to read as follows:</span></p><p class="cs9FD43C8C"><span class="csF2E808A1">&ldquo;(f) Each patient admitted to an office-based medication-assisted treatment program shall be offered testing for blood-borne communicable diseases, including HIV and hepatitis C, as part of the initial assessment.&rdquo;</span></p><p class="cs1AB6177D"><span class="csE736517A">	</span></p><p class="csDB801AB8"><span class="csE736517A">&nbsp;</span></p></body>
